Abstract:Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Dekker grant Aortic stenosis (AS) is a narrowing of the aortic valve opening due to calcification and valve thickening. There are currently no pharmacological treatments for AS, and surgical interventions are the only therapies. To understand the molecular mechanisms underlying AS and test new pharmacological agents, advanced calcification models are required. These models need to closely approach native tissue response to stimuli by maintaining the valvular interstitial cells within their native environment. We have recently developed an ex vivo culture model that fulfills this requirement and allows the induction of calcification in slices of human aortic valves. Our goal is to evaluate the applicability of our ex-vivo calcification model as a pre-clinical test system for potential therapies. Diseased aortic valves were dissected, embedded in agarose, then cut into 300-500 um slices using a vibratome. The use of multiple slices from a single patient ensured proper internal controls. To induce calcification, slices were cultured with 3mM phosphate(n=12), and control slices without phosphate (n=11). To investigate molecular modulation of induced calcification, dexamethasone was added to phosphate cultures(n=9). The slices were assessed for calcification using Alizarin Red staining. ImageJ was used to quantify the percentage of alizarin red-positive area. The average thickness was determined using 3DHISTECH software. In the presence of phosphate, a significant increase in the calcification percentage was observed in cultured valve slices compared with cultures without phosphate (p<0.05). Interestingly, within the phosphate-treated group, two sub-groups could be distinguished, one sub-group exhibiting extensive calcification, while the other showed virtually no sign of calcification. Paired comparisons revealed strong effect of dexamethasone depending on the extent of calcification-inducing capability of phosphate in each patient-sample. More precisely, dexamethasone exhibited potent inhibitory effect on calcification in valvular slices from patients where calcification was stimulated in the presence of phosphate. Conversely, dexamethasone exhibited a stimulatory effect on calcification in slices that did not show a stimulation of calcification in the presence of phosphate. This differential effect was strongly correlated with valve thickness.(r=-0.884,p< 0.01). Our novel ex-vivo calcification model for human aortic valves revealed potential presence of patient-specific effects of pharmacological agents. Dexamethasone can have both stimulatory and inhibitory effects on calcification levels, influenced by phosphate response and valve thickness. As thickness might be indicative of the disease stage, this correlation suggests that the direction of compound's effect might depend on disease stage. Hence, proper understanding of potential opposite effects of compounds is crucial in developing novel therapies.

137 STUDIES ON THE PATHOGENESES Of CALCIFIC AORTIC VALUE DISEASE: THE ROLE OF THE CALCIUM BINDING AMINO ACID δ CARBOXYGLUTAMIC ACID

Association Between Plasma Lipoprotein Levels and Aortic Valve Calcification among Patients with Aortic Valve Replacement Surgery: A Retrospective Study

Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system

Decreased Glucagon-Like Peptide-1 Is Associated With Calcific Aortic Valve Disease: GLP-1 Suppresses the Calcification of Aortic Valve Interstitial Cells

The vitamin K-dependent carboxylation reaction

Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein

Novel ex-vivo calcification model for human aortic valves reveals patient-specific effect of compound

Amyloid and collagen templates in aortic valve calcification

Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis

Lipoprotein(a) and calcific aortic valve stenosis: A systematic review

Role of vitamin K2 and vitamin K cycle enzymes in aortic valvular interstitial cell calcification

Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers

RELATION BETWEEN CALCIUM METABOLISM AND DEVELOPMENT OF AORTIC VALVE STENOSIS

Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification

Involvement of Vitamin K-Dependent Proteins in Vascular Calcification

Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review

Gal knockout pig pericardium: new source of material for heart valve bioprostheses

The Haemodynamic and Pathophysiological Mechanisms of Calcific Aortic Valve Disease

Valvular aortic stenosis: a proteomic insight

Quantification of calcification in atherosclerotic lesions

Calcific aortic valve disease: mechanisms, prevention and treatment